Novonesis (Novozymes A/S)
Trading by management and close relations of management
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen restricted stock units (RSU) program.
Please read the full announcement in PDF.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
dsm-firmenich24.6.2025 07:00:00 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
World Vapers’ Alliance24.6.2025 06:00:00 CEST | Press release
Silent No More: Protesters Demand Consumer Voice at Tobacco Control Summit
Sompo International Holdings Ltd.24.6.2025 05:30:00 CEST | Press release
Sompo announces leadership changes for its Hong Kong Commercial P&C Insurance business
Brookfield Corporation23.6.2025 22:45:00 CEST | Press release
Brookfield Corporation Announces Results of Conversion of its Series 42 Preferred Shares
Novo Nordisk A/S23.6.2025 20:36:11 CEST | Press release
Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom